Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Home Tags GAVI

Tag: GAVI

The € 7.4 billion for Covid-19 product and vaccine development needs a few strings attached

Blog

The € 7.4 billion for Covid-19 product and vaccine development needs a few strings attached

Ellen 't Hoen -

May 5, 2020

Recent Posts

Covid shows the world it needs new rules to deal with pandemics
Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination is pre-eminent problem
US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a reality
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too

Posts by Subject

Access to Medicines ARIPO C-TAP Cancer CDCA competition law Compulsory licensing compulsory licensing for export covid-19 Covid-19 Pool Data exclusivity Delinkage DNDi dolutegravir European Commission European Union evergreening Fair Pricing Gilead Hepatitis C HIV IFPMA LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands orkambi Orphan Drugs Patents PrEP R&D remdesivir Sofosbuvir SPC Supplementary Protection Certificates The Netherlands transparency TRIPS Council TRIPS flexibilities Truvada vaccines WHO WIPO WTO

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

© Newspaper WordPress Theme by TagDiv